• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Germany Epilepsy Market Insights Capsule - 2013

  • ID: 2599187
  • July 2013
  • Region: Germany
  • 25 pages
  • Fore Pharma

The latest research Germany Epilepsy Market Insights Capsule, presents epilepsy market competitive landscape and epilepsy drug forecasts in Germany.

The research finds market events that characterize the Germany epilepsy market. The research includes Germany epilepsy market size estimate for 2012 and forecasts for six years to 2018, epilepsy products market share, neurologists’ drug prescribing trends, late stage epilepsy pipeline products, and epilepsy prevalence in Germany.

This research will help executive track competitor product sales and market share in Germany epilepsy market. It enables informed decision making from R&D to long term marketing strategies. The insights presented in this report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in Germany epilepsy market.

Highlights of the Research:
- Germany epilepsy market analysis
- Competitive landscape in Germany epilepsy market
- Germany epilepsy market forecasts to 2018
- Epilepsy product sales forecast to 2018 in Germany
- Epilepsy late stage pipeline

Note: Product cover images may vary from those shown

1. Epilepsy: Disease Definition
2. Epilepsy Epidemiology in Germany
3. Epilepsy Therapies in Germany
4. Germany Epilepsy Market Analysis
a. Epilepsy Drug Sales Analysis
b. Prescribing Trends
5. Competitive Landscape in Germany Epilepsy market
6. Epilepsy Late Stage Pipeline
7. Germany Epilepsy Market Forecast
a. Epilepsy Drug Sales Forecast
b. Future Competitive Landscape
Table 1: Epilepsy Prevalence in Germany (2012-2018)
Table 2: Epilepsy Therapies Marketed in Germany (2012)
Table 3: Epilepsy Drug Sales in Germany (2012)
Table 4: Epilepsy Late Stage Pipeline (2013)
Table 5: Germany Epilepsy Market Forecast (2012-2018)
Table 6: Epilepsy Drug Sales Forecast in Germany (2012-2018)
Figure 1: Epilepsy Prevalence in Germany (2012-2018)
Figure 2: Germany Epilepsy Market Size (2011-2012)
Figure 3: Epilepsy Products Market Share (%) in Germany (2012)
Figure 4: Germany Epilepsy Market Forecast (2012-2018)
Figure 5: Epilepsy Products Sales Forecast in Germany (2012-2018)
Figure 6: Future Epilepsy Products Market Share (%) in Germany (2018)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S